16 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
as the Agents may reasonably request.
Payment of Expenses. The Company will pay all expenses incident to the performance of its obligations under … ) the fees and expenses of the transfer agent and registrar for the Ordinary Shares, (x) the filing and other fees incident to any review by FINRA
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
incident to the performance of its obligations under this Agreement, including (i) the preparation, printing and filing of the Registration Statement
6-K
EX-10.1
s2zndz hb0x
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
m91dj6me1mr510blq6fs
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
88mswmw27xk99h09ld0z
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
w07f5o0w2ectiy zpd7h
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B3
qga0br 2wgin2i
10 Jul 19
Prospectus supplement
8:18am
F-3
hxde629j8btuzsr
28 Jun 19
Shelf registration (foreign)
9:48am
6-K
EX-99.1
c1mc8rqttv
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
j9evat1e5n
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
zfo23eyj
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
F-1/A
EX-3.2
au4bh58eirey 0wt
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next